Why is Gland Pharma falling/rising?

As of 17-Jul, Gland Pharma Ltd's stock price is rising, currently at Rs 2,005.00, reflecting an increase of Rs 34.25 or 1.74%. The stock has shown strong performance recently, gaining 9.15% over the past week and 14.56% over the past month, significantly outperforming the Sensex, which has declined by 1.12% in the same week and increased by only 0.83% in the past month. Additionally, the stock has been on a consecutive gain streak for the last five days, and it is trading above all key moving averages. The rising investor participation is evident with a delivery volume increase of 177.41% compared to the five-day average, indicating heightened interest in the stock. The company also benefits from a low debt-to-equity ratio and high institutional holdings at 40.18%, suggesting strong confidence from knowledgeable investors.
Broader market context shows that while Gland Pharma has been performing well, the overall market, represented by the Sensex, has not kept pace, particularly in the short term. The stock's recent gains contrast sharply with the benchmark's performance, highlighting its relative strength. This divergence suggests that Gland Pharma is attracting investor interest despite broader market challenges, contributing to its upward price movement.